POET Stock Analysis: POET Technologies | NASDAQ
Semiconductors | NASDAQ, USA | Market Cap: 1.206m USD | 12M Return: -35.5% | CA73044W3021 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 59.8M
Qual. Beats: 0
Rev. Trend: 38.1%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
POET Technologies Inc. is a Canadian-headquartered semiconductor company that designs, develops, manufactures, and sells photonic integrated packaging solutions based on its proprietary POET Optical Interposer platform. The technology enables the integration of electronic and photonic devices onto a single chip using wafer-level semiconductor manufacturing techniques. The company was formerly known as Opel Technologies Inc. before adopting its current name in June 2013, and it is listed on NASDAQ under the ticker POET.
The companys product portfolio includes photonic integrated circuits, optical engines, optical transceiver modules, and light source products. It serves a diverse set of end markets, including data center AI infrastructure, telecommunications (including 5G networks such as PON and GPON), edge computing for machine-to-machine communications, and sensing applications such as LIDAR, Optical Coherence Tomography for medical devices, and virtual reality systems. POET has a strategic collaboration with Lumilens Inc. focused on developing wafer-level photonic integration for AI optical networks.
POET operates globally, with commercial reach spanning North and South America, Europe, Malaysia, Singapore, China, and other parts of Asia. Photonic integration is a sub-segment of the broader semiconductor industry that uses light-based signal transmission instead of purely electrical signals, which is increasingly relevant to data center and AI workloads that demand high bandwidth and energy efficiency. Wafer-level semiconductor manufacturing refers to processing multiple chips simultaneously on a single wafer, a standard approach used to scale production and reduce per-unit costs in the chip industry.
- AI data center demand drives optical interposer order growth
- Strategic Lumilens partnership accelerates AI photonic integration roadmap
- Capital raises and dilution risk persist as R&D spending outpaces revenue
| Net Income: -75.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.05 > 0.02 and ΔFCF/TA 38.41 > 1.0 |
| NWC/Revenue: 44.8k% < 20% (prev 7.55k%; Δ 37.2k% < -1%) |
| CFO/TA -0.04 > 3% & CFO -35.3m > Net Income -75.7m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 24.46 > 1.5 & < 3 |
| Outstanding Shares: last quarter (162.4m) vs 12m ago 100.3% < -2% |
| Gross Margin: -120.7% > 18% (prev -311.4%; Δ 190.7% > 0.5%) |
| Asset Turnover: 0.35% > 50% (prev 0.52%; Δ -0.17% > 0%) |
| Interest Coverage Ratio: -433.6 > 6 (EBIT TTM -84.4m / Interest Expense TTM 195k) |
| A: 0.87 (Total Current Assets 799.5m - Total Current Liabilities 32.7m) / Total Assets 881.8m |
| B: -0.36 (Retained Earnings -320.8m / Total Assets 881.8m) |
| C: -0.17 (EBIT TTM -84.4m / Avg Total Assets 485.7m) |
| D: 24.71 (Book Value of Equity 847.5m / Total Liabilities 34.3m) |
| Altman-Z'' = 29.30 = AAA |
| DSRI: 0.10 (Receivables 390k/1.50m, Revenue 1.71m/468k) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 9.13 (AQ_t 0.07 / AQ_t-1 0.01) |
| SGI: 3.66 (Revenue 1.71m / 468k) |
| TATA: -0.05 (NI -75.7m - CFO -35.3m) / TA 881.8m) |
| Beneish M = 2.96 (Cap -4..+1) = D |
As of October 16, 2026, the stock is trading at USD 5.84 with a total of 12,105,394 shares traded. Over the past week, the price has changed by -21.29%, over one month by -21.40%, over three months by -33.71% and over the past year by -35.47%.
Current recommended Stop Loss: 5.30 (which is 9.2% or 1.2 ATR below the current price).
POET Technologies has no consensus analysts rating.
| Analysts Target Price | 14.8 | 152.6% |
P/S = 704.174
P/B = 1.6683
Revenue TTM = 1.71m USD
EBIT TTM = -84.4m USD
EBITDA TTM = -80.7m USD
Long Term Debt = 1.61m USD (estimated: total debt 7.80m - short term 6.19m)
Short Term Debt = 6.19m USD (from shortTermDebt, last quarter)
Debt = 9.80m USD (from shortLongTermDebtTotal, last quarter) + Leases 2.00m
Net Debt = -786.5m USD (calculated: Debt 9.80m - CCE 796.3m)
Enterprise Value = 419.7m USD (1.21b + Debt 9.80m - CCE 796.3m)
Interest Coverage Ratio = -433.6 (Ebit TTM -84.4m / Interest Expense TTM 195k)
EV/FCF = -10.38x (Enterprise Value 419.7m / FCF TTM -40.4m)
FCF Yield = -9.63% (FCF TTM -40.4m / Enterprise Value 419.7m)
FCF Margin = -2.36k% (FCF TTM -40.4m / Revenue TTM 1.71m)
Net Margin = -4.42k% (Net Income TTM -75.7m / Revenue TTM 1.71m)
Gross Margin = -120.7% ((Revenue TTM 1.71m - Cost of Revenue TTM 3.78m) / Revenue TTM)
Gross Margin QoQ = -80.19% (prev -90.25%)
Tobins Q-Ratio = 0.48 (Enterprise Value 419.7m / Total Assets 881.8m)
Interest Expense / Debt = 1.99% (Interest Expense 195k / Debt 9.80m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -66.7m (EBIT -84.4m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 24.46 (Total Current Assets 799.5m / Total Current Liabilities 32.7m)
Debt / Equity = 0.01 (Debt 9.80m / totalStockholderEquity, last quarter 847.5m)
Debt / EBITDA = 9.75 (negative EBITDA) (Net Debt -786.5m / EBITDA -80.7m)
Debt / FCF = 19.46 (negative FCF - burning cash) (Net Debt -786.5m / FCF TTM -40.4m)
Total Stockholder Equity = 386.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -15.59% (Net Income -75.7m / Total Assets 881.8m)
RoE = -19.59% (Net Income TTM -75.7m / Total Stockholder Equity 386.6m)
RoCE = -21.75% (EBIT -84.4m / Capital Employed (Equity 386.6m + L.T.Debt 1.61m))
RoIC = -7.80% (negative operating profit) (NOPAT -66.7m / Invested Capital 855.2m)
WACC = 19.75% (E(1.21b)/V(1.22b) * Re(19.90%) + D(9.80m)/V(1.22b) * Rd(1.99%) * (1-Tc(0.21)))
Discount Rate = 19.90% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 91.40 | Cagr: 74.24%
[DCF] Fair Price = unknown (Cash Flow -40.4m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.10 | # QB: 0
Revenue Correlation: 38.10 | Revenue CAGR: 57.73% | SUE: -0.48 | # QB: 0
EPS current Quarter (2026-09-30): EPS=-0.05 | Chg30d=+16.67% | Revisions=+25% | Analysts=1
EPS current Year (2026-12-31): EPS=-0.23 | Chg30d=+4.17% | Revisions=+25% | GrowthEPS=+42.8% | GrowthRev=+211.2%
EPS next Year (2027-12-31): EPS=-0.17 | Chg30d=+0.00% | Revisions=-25% | GrowthEPS=+26.1% | GrowthRev=+2864.5%